Doç. Dr. ABDURRAHMAN SONER ŞENEL

Yayın Ağı

Makaleler 71

1. The miliyer tuberculosis mimirating oropharynx carcinoma in a patient using anti-TNF: Review of the literature

KAHRAMAN DENİZHAN T., Kiziltepe M., Kaplan H., Kokoglu E. O., CENGİZ C. B., ŞENEL A. S.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.16, ss.128-131, 2025 (ESCI)

2. Romatoid artrit hastalarında eşlik eden hastalıkların varlığı, başlangıç tümör nekroz faktörü inhibitörü tedavisine yanıtı ve tedavi devam oranlarını etkiler mi?

Inel T. Y., kocaer s. b., Dalkılıç E., Akar S., Koca S. S., SENEL A. S., et al.

Journal of health sciences and medicine (Online) , cilt.8, sa.2, ss.292-297, 2025 (TRDizin)

3. Frequency of severe infections in rheumatic disease patients receiving bDMARDs post-kidney transplantation: a multicenter study.

Yıldırım T. D., Kökoğlu E., Coşkun B. N., Yıldırım D., Basaran E., Şenel A. S., et al.

Clinical rheumatology , cilt.44, sa.2, ss.831-838, 2025 (SCI-Expanded, Scopus)

4. Rare association between ankylosing spondylitis and paget's disease: A case of pagetic vertebral ankylosis

Cengiz C. B., Kızıltepe M., Kaplan H., Kökoğlu E., Denizhan T., Şenel A. S.

ARCHIVES OF OSTEOPOROSIS , cilt.20, sa.1, 2024 (SCI-Expanded, Scopus)

5. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis

Uslu S., Gülle S., ŞEN G., ÇAPAR S., Senel S., DALKILIÇ H. E., et al.

Journal of Clinical Medicine , cilt.13, sa.23, 2024 (SCI-Expanded, Scopus)

6. Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study

Uslu S., Gulle S., ŞEN G., ÇEFLE A., YILMAZ S., Kocaer S. B., et al.

SCIENTIFIC REPORTS , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)

7. Concurrent Evaluation of Restless Leg Syndrome, Neuropathic Pain, and Quality of Life in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: Single-Center Data

Kızıltepe M., Oğuz Kökoğlu E., Kaplan H., Şaş S., Kahraman Denizhan T., Cengiz C. B., et al.

CUREUS , cilt.16, sa.11, ss.1-11, 2024 (ESCI)

8. Case report: Cutaneous polyarteritis nodosa presenting with ulcers in atypical localizations and atypical skin rashes: A report of a rare case.

Kökoğlu E., Kontaş O., Kaplan H., Cengiz C. B., Şenel A. S.

International journal of rheumatic diseases , cilt.27, sa.8, 2024 (SCI-Expanded, Scopus)

9. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results

Uslu S., GÜLLE S., URAK Ö., ŞEN G., Dalkilic E., Senel S., et al.

ARCHIVES OF RHEUMATOLOGY , cilt.39, ss.232-241, 2024 (SCI-Expanded, Scopus, TRDizin)

10. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry

KARAKAŞ A., GÜLLE S., CAN G., DALKILIÇ H. E., AKAR S., KOCA S. S., et al.

MODERN RHEUMATOLOGY , cilt.34, sa.3, ss.584-591, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. An Investigation Into Hearing Functions in Patients With Takayasu Arteritis

Koekoglu E., Koekoglu K., ŞENEL A. S., Tektas N., KIZILTEPE M., SOLGUNTEKİN E., et al.

JOURNAL OF CLINICAL PRACTICE AND RESEARCH , cilt.46, sa.2, ss.185-190, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

12. Evaluation of Voice in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitides

KÖKOĞLU K., KIZILTEPE M., Çapar A. O., Kökoğlu E., TEKTAŞ N., ŞENEL A. S.

Turkish Journal of Ear Nose and Throat , cilt.34, sa.2, ss.55-59, 2024 (Scopus, TRDizin)

13. Evaluation of Predictors Associated with COVID-19 Pneumonia in Rheumatic Patients Using Biological or Targeted Therapies: Results from a Tertiary Center in Turkey

ELDEMİR Y. Ö., KAPLAN H., ŞAŞ S., ŞENEL S.

HASEKI TIP BULTENI , cilt.5, sa.61, ss.339-347, 2023 (ESCI, Scopus, TRDizin)

14. A case that developed acute generalized exanthematous pustulosis after hydroxychloroquine use and did not follow the ordinary healing process despite drug discontinuation Hidroksiklorokin kullanımından sonra akut generalize ekzantematöz püstüloz gelişen ve ilaç kesilmesine rağmen olağan iyileşme sürecini takip etmeyen bir olgu

KIZILTEPE M., OĞUZ KÖKOĞLU E., Eldemir Y. Ö., Şaş S., ŞENEL A. S.

Journal of Turkish Society For Rheumatology , cilt.15, sa.3, ss.171-174, 2023 (Scopus, TRDizin)

15. Skeletal Muscle Mass, Muscle Strength, and Quality of Life in Adult Patients with Familial Mediterranean Fever: A Comparative Study with Healthy Controls

Cüce İ., Yıldızhan R., KONCA S. K., Kara H., Veziroğlu E., ÇAKIR T. F., et al.

Genel Tıp Dergisi , cilt.33, sa.5, ss.536-540, 2023 (TRDizin)

16. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?

Çandereli Z. Ö., Arslan T., Özdamar Ö., Yay M., Karaçayli Ü., Şişman-Kitapçi N., et al.

Clinical and experimental rheumatology , cilt.41, sa.10, ss.2078-2086, 2023 (SCI-Expanded, Scopus)

17. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology

TEMİZ KARADAĞ D., Yalcinkaya Y., AKDOĞAN A., Avanoglu A., Bes C., BİRLİK A. M., et al.

Clinical and experimental rheumatology , cilt.41, sa.8, ss.1679-1687, 2023 (SCI-Expanded, Scopus)

18. Patient diagnosed with immunoglobulin G4-related autoimmune pancreatitis after total pancreatoduodenectomy, gastrectomy, and splenectomy: A case report

Kökoğlu E. O., KIZILTEPE M., ŞAŞ S., ELDEMİR Y. Ö., Ünal T. D. K., ŞENEL A. S.

International Journal of Gastrointestinal Intervention , cilt.12, sa.2, ss.99-102, 2023 (ESCI, Scopus)

19. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis

Yarkan Tuğsal H., KENAR ARTIN G., CAN G., ÇAPAR S., Zengin B., Akar S., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.4, ss.970-978, 2023 (SCI-Expanded, Scopus, TRDizin)

20. RECURRENT SPONTANEOUS PNEUMOTHORAX UNDER NINTEDANIB TREATMENT IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

Senel A. S., Denizhan T., Kiziltepe M., Kokoglu E., Tutar N.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.40, sa.4, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry

Karataş A., Pişkin Sağir R., Koca S. S., DALKILIÇ H. E., CAN G., PEHLİVAN Y., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1321-1329, 2023 (SCI-Expanded, Scopus, TRDizin)

22. Are Follistatin-Like Protein 1 and Follistatin-Like Protein 3 Associated with Inflammatory Processes in Patients with Familial Mediterranean Fever?

KAPLAN H., ÇALIŞ M., YAZICI C., GÜNTÜRK İ., CÜCE İ., ŞENEL S.

NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI , cilt.10, ss.306-313, 2023 (ESCI, Scopus, TRDizin)

23. A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry

YAZICI A., ÖZDEMİR IŞIK Ö., Dalkilic E., KOCA S. S., PEHLİVAN Y., Senel S., et al.

SCIENTIFIC REPORTS , cilt.12, sa.1, 2022 (SCI-Expanded, Scopus)

24. The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort

USLU S., GÜLLE S., CAN G., Senel S., ÇAPAR S., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , ss.847-849, 2022 (SCI-Expanded, Scopus)

25. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort

GÜLLE S., KARAKAŞ A., CAN G., Senel S., ÇAPAR S., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.74, ss.843-845, 2022 (SCI-Expanded, Scopus)

26. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium

DÜNDAR M., FAHRİOGLU U., Yildiz S. H., Bakir-Gungor B., TEMEL Ş. G., AKIN H., et al.

FUNCTIONAL & INTEGRATIVE GENOMICS , cilt.22, sa.3, ss.291-315, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry

Onen F., CAN G., ÇAPAR S., Dalkilic E., PEHLİVAN Y., Senel S., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.9, sa.2, ss.82-87, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma

28. DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS

Koca S. S., PEHLİVAN Y., Akar S., Senel S., Karadeniz H., Sosyal O., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1317, 2021 (SCI-Expanded, Scopus)

29. LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN AXIAL SPONDYLOARTHRITIS IS HIGHER: DATA FROM TURKBIO

Koca S. S., PEHLİVAN Y., Akar S., Senel S., Guler A. A., Sosyal O., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1266-1267, 2021 (SCI-Expanded, Scopus)

30. A NATIONAL, MULTICENTER, SECONDARY DATA USE STUDY EVALUATING EFFICACY AND RETENTION OF FIRST-LINE BIOLOGIC TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-LIFE SETTING FROM TURKBIO REGISTRY

Yazici A., Isik O. O., DALKILIÇ H. E., Koca S. S., PEHLİVAN Y., Senel S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1140-1141, 2021 (SCI-Expanded, Scopus)

31. Moderation analysis exploring associations between age and mucocutaneous activity in Behcet's syndrome: A multicenter study from Turkey

MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., Armagan B., et al.

JOURNAL OF DERMATOLOGY , cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus)

32. A case of fulminant demyelinating disease associated with golimumab treatment.

Yetkin M. F., Kendirci M., İsmailoğulları S., Gültekin M., Baydemir R., Sarılar A. Ç., et al.

Clinical neurology and neurosurgery , cilt.195, ss.105887, 2020 (SCI-Expanded, Scopus)

33. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study

Mumcu G., Yay M., Aksoy A., Tas M. N., Armagan B., Sari A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study.

Mumcu G., Karacayli Ü., Yay M., Aksoy A., Taş M. N., Armağan B., et al.

Clinical and experimental rheumatology , sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus)

35. The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia

YAŞAR BİLGE N. Ş., SARI İ., Solmaz D., ŞENEL A. S., Emmungil H., KILIÇ L., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , sa.2, ss.472-477, 2019 (SCI-Expanded, Scopus, TRDizin)

36. Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report

EROĞLU E., SİPAHİOĞLU M. H., Senel S., Ertas S. K., SAVAŞ Ş., ÖZTÜRK F., et al.

WORLD JOURNAL OF CLINICAL CASES , cilt.7, sa.16, ss.2309-2315, 2019 (SCI-Expanded, Scopus)

37. Exon 2: Is it the good police in familial mediterranean fever?

YAŞAR BİLGE N. Ş., Solmaz D., Senel S., Emmungil H., KILIÇ L., Oner S. Y., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , sa.1, ss.34-37, 2019 (ESCI, TRDizin)

38. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

Akar S., Cetin P., KALYONCU U., KARADAĞ Ö., SARI İ., Cinar M., et al.

ARTHRITIS CARE & RESEARCH , sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Comparison of early versus late onset familial Mediterranean fever

YAŞAR BİLGE N. Ş., SARI İ., Solmaz D., ŞENEL A. S., Emmungil H., KILIÇ L., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , sa.4, ss.880-884, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever

BOSTANCI V., Toker H., ŞENEL A. S., POYRAZ Ö., AKPINAR A., PİRİM GÖRGÜN E., et al.

CLINICAL ORAL INVESTIGATIONS , sa.1, ss.469-475, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. The management of gout in different clinical specialties in Turkey: a patient-based survey

ÖZTÜRK M. A., Mercan R., Gok K., Onat A. M., Kisacik B., Kimyon G., et al.

CLINICAL RHEUMATOLOGY , sa.12, ss.3019-3024, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study

Ozen G., Inanc N., Unal A. U., Bas S., Kimyon G., Kisacik B., et al.

JOURNAL OF RHEUMATOLOGY , sa.5, ss.893-900, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. The role of neutrophil lymphocyte ratio to leveragethe differential diagnosis of familial Mediterraneanfever attack and acute appendicitis

KÜÇÜK A., EROL M. F., ŞENEL S., EROLER E., YUMUN H. A., USLU A. U., et al.

Korean J Intern Med , cilt.31, ss.386-391, 2016 (Scopus)

44. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A

KALYONCU U., Emmungil H., Onat A. M., Yilmaz S., Kasifoglu T., Akar S., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , sa.4, ss.149-154, 2015 (ESCI, TRDizin)

45. Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia

Ozaslan E., Eroglu E., Gok K., ŞENEL A. S., Baldane S., Akyol L., et al.

ROMANIAN JOURNAL OF INTERNAL MEDICINE , cilt.53, sa.3, ss.282-285, 2015 (ESCI, Scopus) Sürdürülebilir Kalkınma

46. Prevalence of periodontal disease in patients with Familial Mediterranean Fever: A cohort study from central Turkey

Bostanci V., Toker H., Senel S., Sahin S.

QUINTESSENCE INTERNATIONAL , cilt.45, sa.9, ss.743-748, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Diagnostic dilemma of paraneoplastic arthritis: case series

Kisacik B., Onat A. M., KAŞİFOĞLU T., PEHLİVAN Y., Pamuk O. N., DALKILIÇ H. E., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.17, sa.6, ss.640-645, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Impact of rheumatoid arthritis in Turkey: a questionnaire study.

Direskeneli H., Akkoç N., Bes C., Cakir N., Cefle A., Cobankara V., et al.

Clinical and experimental rheumatology , cilt.32, sa.4, ss.477-83, 2014 (SCI-Expanded, Scopus)

49. Effect of Chronic Periodontitis on Serum and Gingival Crevicular Fluid Oxidant and Antioxidant Status in Patients With Familial Mediterranean Fever Before and After Periodontal Treatment

Bostanci V., Toker H., Senel S., Ozdemir H., Aydin H.

JOURNAL OF PERIODONTOLOGY , cilt.85, sa.5, ss.706-712, 2014 (SCI-Expanded, Scopus)

50. Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?

Deveci K., Korkmaz S., Senel S., Deveci H., Sancakdar E., Uslu A. U., et al.

RENAL FAILURE , cilt.36, sa.3, ss.339-344, 2014 (SCI-Expanded, Scopus)

51. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study

Kasifoglu T., Bilge S. Y., Sari I., Solmaz D., Senel S., Emmungil H., et al.

RHEUMATOLOGY , cilt.53, sa.4, ss.741-745, 2014 (SCI-Expanded, Scopus)

52. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?

Korkmaz S., Uslu A. U., Sahin S., Senel S., Sencan M.

PLATELETS , cilt.25, sa.5, ss.343-347, 2014 (SCI-Expanded, Scopus)

53. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis

Safak S., Uslu A. U., Serdal K., Turker T., Soner S., Lutfi A.

AFRICAN HEALTH SCIENCES , sa.4, 2014 (SCI-Expanded, Scopus)

54. Evaluation of hearing in patients with familial Mediterranean fever

Polat K., Uysal I. O., Senel S., Güler C., Durmuş K., Muderris S.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.270, sa.11, ss.2871-2874, 2013 (SCI-Expanded, Scopus)

55. Demographic and clinical features of gout patients in Turkey: a multicenter study

Ozturk M. A., Kaya A., Senel S., Donmez S., Balkarli A., Cobankara V., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.33, sa.4, ss.847-852, 2013 (SCI-Expanded, Scopus)

56. Assesment life quality of familial mediterranean fever patients by short form-36 and its relationship with disease parameters

Sahin S., Yalçın İ., Senel S., Ataseven H., Uslu A. U., Yildirim O., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.17, sa.7, ss.958-963, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients

Deveci K., Gokakin A. K., Senel S., Deveci H., Uslu A. U., Sancakdar E.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.17, sa.2, ss.253-260, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever?

Sahin S., Senel S., Ataseven H., Yalçın I.

PLATELETS , cilt.24, sa.4, ss.320-323, 2013 (SCI-Expanded, Scopus)

59. Is Neutrophil/Lymphocyte Ratio Associated with Subclinical Inflammation and Amyloidosis in Patients with Familial Mediterranean Fever?

Uslu A. U., Deveci K., Korkmaz S., Aydin B., Senel S., Sancakdar E., et al.

BIOMED RESEARCH INTERNATIONAL , 2013 (SCI-Expanded, Scopus)

60. Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study

Deveci K., Gokakin A. K., Boztosun A., Deveci H., Senel S., Uslu A. U., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.17, sa.2, ss.261-265, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis

Senel S., Cobankara V., Taskoylu O., Karasu U., Karapinar H., Erdis E., et al.

JOURNAL OF INVESTIGATIVE MEDICINE , cilt.60, sa.1, ss.62-65, 2012 (SCI-Expanded, Scopus)

62. Effect of Infliximab Treatment on QT Intervals in Patients With Ankylosing Spondylitis

Senel S., Cobankara V., Taskoylu O., Guclu A., Evrengul H., Kaya M. G.

JOURNAL OF INVESTIGATIVE MEDICINE , cilt.59, sa.8, ss.1273-1275, 2011 (SCI-Expanded, Scopus)

63. The efficacy and safety of etanercept in patients with rheumatoid arthritis and spondyloarthropathy on hemodialysis

ŞENEL S., Kısacık B., Ugan Y., Kaşifoğlu T., Tunç E., Çobankara V.

CLINICAL RHEUMATOLOGY , cilt.30, sa.10, ss.1369-1372, 2011 (SCI-Expanded, Scopus)

64. Anti-aquaporin-4 Antibody Positive Relapsing Neuromyelitis Optica in a Patient With Systemic Lupus Erythematosus

KAYIM YILDIZ Ö., Balaban H., Senel S.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.28, sa.3, ss.376-379, 2011 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

65. Wegener Granulomatosis Accompanying Rheumatoid Arthritis: A Case Report

Ozturk E., Kiter G., Cobankara V., Senel S., Yuncu G.

TURKISH THORACIC JOURNAL , sa.2, ss.72-75, 2011 (ESCI, TRDizin) Sürdürülebilir Kalkınma

66. Is there a role for TNF-α antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

Distler J. H. W., Jordan S., Airo P., Alegre-Sancho J. J., Allanore Y., Gurman A. B., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.2, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma

Kilickap S., AKSOY S., Senel S., ATASEVEN H.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.6, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Brain natriuretic peptide and P wave duration in dialysis patients

TAŞKAPAN M. Ç., Senel S., Ulutas O., Aksoy Y., Sahin I., Kosar F., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.39, sa.2, ss.603-608, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Platelet activity and serum homocysteine levels in patients with end-stage renal failure with regard to dialysis modality

Taskapan H., Senel S., Ulutas O., TAŞKAPAN M. Ç., AKSOY Y., Kosar F., et al.

RENAL FAILURE , cilt.28, sa.4, ss.303-308, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature

Senel S., KAYA E., Aydogdu I., ERKURT M. A., Kuku I.

RHEUMATOLOGY INTERNATIONAL , cilt.26, sa.9, ss.857-861, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Brain natriuretic peptide and its relationship to left ventricular hypertrophy in patients on peritoneal dialysis or hemodialysis less than 3 years

TAŞKAPAN M. Ç., Ulutas O., AKSOY Y., Senel S., Sahin I., Kosar F., et al.

RENAL FAILURE , cilt.28, sa.2, ss.133-139, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 33

1. Anti-SAE1, anti-SS-A ve anti-cN1A antikorlarının eş zamanlı pozitif olduğu bir dermatomiyozit olgusu

KAPLAN H., OĞUZ KÖKOĞLU E., KIZILTEPE M., KAHRAMAN DENİZHAN T., CENGİZ C. B., ŞENEL A. S.

XXIV. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 Ekim 2024, cilt.17, ss.308-309, (Özet Bildiri)

2. SPONDİLOARTROPATİLİ HASTALARDA BİYOLOJİK TEDAVİYE PRİMER YANITSIZLIK ILE İLİŞKİLİ FAKTÖRLERİN DEĞERLENDİRİLMESİ

OĞUZ KÖKOĞLU E., KAPLAN H., ŞENEL A. S.

Spondiloartritler 2024, İzmir, Türkiye, 19 Eylül 2024, ss.9-11, (Özet Bildiri)

3. CHARACTERISTICS OF PATIENTS WHO RECEIVED BIOLOGICAL TREATMENT AFTER KIDNEY TRANSPLANTATION AND THE INCIDENCE OF SERIOUS INFECTIONS: A MULTICENTER STUDY

Yildirim T. D., Kokoglu E. O., COŞKUN ONAN B., Yildirim D., Senel S., PEHLİVAN Y., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1987-1988, (Özet Bildiri)

4. DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO

Erez Y., Karakas A., Kocaer S. B., Inel T. Y., Gulle S., Avsar A. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.418-419, (Özet Bildiri)

5. Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort

Tascilar K., Aydin S. Z., Akar S., Aksu K., Bakirci S., Bayindir O., et al.

Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Georgia, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

6. The Efficacy and Safety of Anti-TNFα Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data from TURKBIO Registry

Uslu S., CAN G., ÇEFLE A., Yilmaz S., Kocaer S. B., Inel T. Y., et al.

Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Georgia, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration

Ornbjerg L. M., Brahe C. H., Loft A. G., Askling J., Ciurea A., Mann H., et al.

Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Georgia, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

8. THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY

Uslu S., CAN G., ÇEFLE A., Yilmaz S., Kocaer S. B., Inel T. Y., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, ss.896, (Özet Bildiri)

9. DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DEPEND ON THE REASON FROM WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION

Ornbjerg L., Brahe C. H., Loft A. G., Askling J., Ciurea A., Mann H., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, ss.872-873, (Özet Bildiri)

10. Ailevi Akdeniz Ateşi Olan Hastalarda Follistatin-like protein 1 ve Follistatin-like 3 Düzeylerinin Hastalık Aktivasyonu ve Mutasyon Tipi ile İlişkisi

KAPLAN H., ÇALIŞ M., YAZICI C., GÜNTÜRK İ., CÜCE İ., ŞENEL S.

Türk Romatoloji Kongresi 2019, Antalya, Türkiye, 20 Mart 2019, (Özet Bildiri)

11. Skleroderma hastalarInIn nutrisyonel durumunundeğerlendirilmesi

ŞENEL S., YILMAZ E., YILDIRIM A., KETENCİ ERTAŞ Ş., EROL K., YAZICI C.

19. ULUSAL ROMATOLOJİ KONGRESİ, Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.1-220, (Özet Bildiri)

12. Evaluation of serum micronutrients level and nutritional status of scleroderma patients a single-centered, cross sectional cohort study from Turkey

YILMAZ E., ŞENEL S., GÜNDOĞAN K., GÖK K., EROL K., KETENCİ ERTAŞ Ş., et al.

ESPEN CONGRESS, Madrid, İspanya, 1 - 04 Eylül 2018, cilt.37, ss.225, (Özet Bildiri)